BEDFORD, NS / ACCESS Newswire / March 31, 2025 / Silver Spruce Resources, Inc. ("Silver Spruce" or the "Company") - (TSXV:SSE) announces dropping its Option to earn 100% interest in the 14,790-hectare ...
EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG / Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung ...
Dave Treat to lead Pearson's digital and technology operation, expanding his current architectural and innovation responsibilities LONDON, March 31, 2025 /PRNewswire/ -- Pearson (FTSE: PSON.L), the ...
The board of directors of Starbreeze AB has appointed Adolf Kristjansson as new CEO. Adolf will assume his position on April 1st, 2025. He replaces the current interim CEO, Mats Juhl, who will continu ...
Copenhagen, March 31, 2025RISMA Systems A/S closes 2024 with an Annual Recurring Revenue at 42.0 MDKK equivalent to a growth of 24% from 33.8 MDKK end of 2023 Key figurs ...
For over 30 years, EUROMONEY has been the benchmark for awards in the European banking industry. In order to recognize the many independent wealth managers/EAM/MFOs ...
Der Goldpreis schmilzt nach oben, aber die Abwärtsrisiken nehmen ab, meint Daniel Ghali, Senior Commodity Strategist bei TDS. Es gibt wenig Spielraum für Goldverkäufe "Makrofonds haben aufgrund von Ri ...
Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced that ...
Reiterates 2025 guidance of $80 million to $90 million in revenue and mid-40s percentage gross margin - SAN DIEGO, CA, March 31, 2025 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the ...
Toronto, Ontario - (31. März 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: M6B) ("Neural" oder das "Unternehmen"), ein ethnobotanisches Arzneimittelforschungsunternehmen, das sich der Entwicklung ...
So ist Börse: Kurz nachdem Softing-CEO Wolfgang Trier im Dezember 2024 die Jahresprognose erneut nach unten korrigieren musste und kaum noch jemand einen Pfifferling auf die Aktie setzen mochte, dreht ...
AVA6000 Phase 1b expansion cohorts enrolling with data targeted for later in 2025 AVA6103 IND-enabling studies underway with a Phase 1 trial anticipated to begin in the first quarter of 2026 Multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results